Literature DB >> 7758521

Omphalocele in a newborn baby exposed to sodium valproate in utero.

T Boussemart1, D Bonneau, G Levard, M Berthier, D Oriot.   

Abstract

We report on a newborn baby, exposed to valproic acid in utero, with the typical dysmorphic features of the fetal valproate syndrome and omphalocele. One identical case has already been reported after valproic acid exposure in utero.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7758521     DOI： 10.1007/BF01954275

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  11 in total

1.  Teratogenesis of calcium valproate in rabbits.

Authors:  J A Petrere; J A Anderson; R Sakowski; J E Fitzgerald; F A de la Iglesia
Journal:  Teratology       Date:  1986-12

2.  Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.

Authors:  E Jäger-Roman; A Deichl; S Jakob; A M Hartmann; S Koch; D Rating; R Steldinger; H Nau; H Helge
Journal:  J Pediatr       Date:  1986-06       Impact factor: 4.406

3.  Congenital liver damage after treatment of mother with valproic acid and phenytoin?

Authors:  I Felding; A Rane
Journal:  Acta Paediatr Scand       Date:  1984-07

Review 4.  Teratogen update: valproic acid.

Authors:  E J Lammer; L E Sever; G P Oakley
Journal:  Teratology       Date:  1987-06

5.  Clinical manifestation of prenatal exposure to valproic acid using case reports and epidemiologic information.

Authors:  M L Martínez-Frías
Journal:  Am J Med Genet       Date:  1990-10

Review 6.  Developmental toxicity of valproic acid.

Authors:  D Cotariu; J L Zaidman
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

7.  Valproic acid and congenital malformations. A case report.

Authors:  E W Bantz
Journal:  Clin Pediatr (Phila)       Date:  1984-06       Impact factor: 1.168

8.  Strain differences in the teratogenicity induced by sodium valproate in cultured mouse embryos.

Authors:  I Naruse; M D Collins; W J Scott
Journal:  Teratology       Date:  1988-07

Review 9.  Verification of the fetal valproate syndrome phenotype.

Authors:  H H Ardinger; J F Atkin; R D Blackston; L J Elsas; S K Clarren; S Livingstone; D B Flannery; J M Pellock; M J Harrod; E J Lammer
Journal:  Am J Med Genet       Date:  1988-01

10.  Fetal valproate syndrome: is there a recognisable phenotype?

Authors:  R M Winter; D Donnai; J Burn; S M Tucker
Journal:  J Med Genet       Date:  1987-11       Impact factor: 6.318
View more
  4 in total

1.  Ultrastructure of Purkinje cell perikarya and their dendritic processes in the rat cerebellar cortex in experimental encephalopathy induced by chronic application of valproate.

Authors:  M E Sobaniec-Lotowska
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

Review 2.  Valproic acid use in psychiatry: issues in treating women of reproductive age.

Authors:  D Kennedy; G Koren
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

Review 3.  Epilepsy during pregnancy: focus on management strategies.

Authors:  Laura M Borgelt; Felecia M Hart; Jacquelyn L Bainbridge
Journal:  Int J Womens Health       Date:  2016-09-19

4.  Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability.

Authors:  Jill Clayton-Smith; Rebecca Bromley; John Dean; Hubert Journel; Sylvie Odent; Amanda Wood; Janet Williams; Verna Cuthbert; Latha Hackett; Neelo Aslam; Heli Malm; Gregory James; Lena Westbom; Ruth Day; Edmund Ladusans; Adam Jackson; Iain Bruce; Robert Walker; Sangeet Sidhu; Catrina Dyer; Jane Ashworth; Daniel Hindley; Gemma Arca Diaz; Myfanwy Rawson; Peter Turnpenny
Journal:  Orphanet J Rare Dis       Date:  2019-07-19       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.